Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.5%

2 terminated/withdrawn out of 364 trials

Success Rate

97.2%

+10.7% vs industry average

Late-Stage Pipeline

16%

60 trials in Phase 3/4

Results Transparency

1%

1 of 69 completed trials have results

Key Signals

95 recruiting1 with results

Enrollment Performance

Analytics

N/A
73(35.4%)
Phase 2
42(20.4%)
Phase 3
32(15.5%)
Phase 4
28(13.6%)
Phase 1
23(11.2%)
Early Phase 1
8(3.9%)
206Total
N/A(73)
Phase 2(42)
Phase 3(32)
Phase 4(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (364)

Showing 20 of 364 trials
NCT06284642Phase 4Recruiting

Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)

Role: collaborator

NCT07565948Active Not Recruiting

Sofosbuvir/Velpatasvir/Voxilaprevir Salvage Therapy in Hepatitis C Patients Who Relapsed After DAA Treatment

Role: lead

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT06674226Phase 4Recruiting

Effects of Ciprofol on Postoperative Delirium and Outcomes in Elderly Patients Undergoing Major Thoracic Surgery

Role: collaborator

NCT06597227Not ApplicableRecruiting

Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy

Role: collaborator

NCT07518251Not ApplicableRecruiting

CompaRison of FEmorofemoral Bypass and Left-Heart ByPass Techniques in Open Thoracoabdominal AortIc Aneurysm Repair

Role: collaborator

NCT07361796Not ApplicableRecruiting

The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster

Role: collaborator

NCT06681948Not ApplicableCompleted

The Ketogenic Diet in the Treatment of Alzheimer's Disease

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT05020106Recruiting

The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Role: collaborator

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT04850053Recruiting

Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Role: collaborator

NCT07482670Not Yet Recruiting

Efficacy and Safety of Camrelizumab Plus Rivoceranib and Local Therapy for Hepatocellular Carcinoma With Lung Metastases (CAPLocal) : A Multicentre, Single-Arm,Prospective Cohort Study

Role: lead

NCT02405676Phase 2Active Not Recruiting

BNHL-2015 for Children or Adolescents in China

Role: collaborator

NCT06563245Phase 2Recruiting

Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment

Role: collaborator

NCT05681260Phase 3Recruiting

Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)

Role: collaborator

NCT02845882Phase 3Active Not Recruiting

LBL-2016 for Children or Adolescents in China

Role: collaborator

NCT07278947Not ApplicableNot Yet Recruiting

ACT-based Parenting Program for Caregivers of Children With Hearing Loss Post-cochlear: A Pilot Randomised Controlled Trial

Role: collaborator

NCT07459296Phase 3Recruiting

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Role: collaborator

NCT07083154Phase 3Recruiting

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Role: collaborator